Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.​
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you. ​
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities. ​
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless. ​
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest. ​
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions. ​
- Other sectors: From media to academia, we work with sectors as diverse as our data. ​
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on: ​
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.​
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge. ​
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them. ​
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.​
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform. ​
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Daratumumab in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Relapsed Acute Myeloid Leukemia Drug Details: Daratumumab...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy (FECD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy (FECD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ripasudil Hydrochloride Hydrate in Fuchs Endothelial Corneal Dystrophy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Acotiamide Hydrochloride in Esophageal Motility Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acotiamide Hydrochloride in Esophageal Motility Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Acotiamide Hydrochloride in Esophageal Motility DisordersDrug Details:Acotiamide hydrochloride (Acofide, YM-443, and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Pasireotide in Medullary Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pasireotide in Medullary Thyroid Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pasireotide in Medullary Thyroid Cancer Drug Details: Pasireotide (Signifor, Upelior) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Nilotinib in Pigmented Villonodular Synovitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nilotinib in Pigmented Villonodular Synovitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nilotinib in Pigmented Villonodular Synovitis Drug Details: Nilotinib (Tasigna, AMN107)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Regorafenib in Chordoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Regorafenib in Chordoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Regorafenib in Chordoma Drug Details: Regorafenib (BAY 73-4506, Stivarga) is an anti-neoplastic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ixazomib Citrate in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixazomib Citrate in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ixazomib Citrate in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic LymphadenopathyDrug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Colestilan Chloride in Functional (Non Ulcer) Dyspepsia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Colestilan Chloride in Functional (Non Ulcer) Dyspepsia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Colestilan Chloride in Functional (Non Ulcer) DyspepsiaDrug Details: Colestilan chloride...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Liver Failure (Hepatic Insufficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Liver Failure (Hepatic Insufficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cenobamate in Liver Failure (Hepatic Insufficiency)Drug Details:Cenobamate (Xcopri/ Ontozry) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Omidubicel in Hemoglobinopathies
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Omidubicel in Hemoglobinopathies report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Omidubicel in Hemoglobinopathies Drug Details: Omidubicel (Omisirge) is a hematological agents. It...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.